TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY
Mark Identification

TIME-POINT: TANESPIMYCIN IN MYELOMA EVALUATION: PERFORMANCE OF HSP 90 INHIBITOR AS INITIAL THERAPY

Serial Number

77795574

Filing Date

Aug 3, 2009

Trademark by

BRISTOL-MYERS SQUIBB COMPANY

Classification Information

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Computer and Scientific